Notably, four portfolio companies-- Agnikul, ePlane, CynLr, and GalaxEye -- of deep-tech investor Speciale Invest made it to the list.
As the policy was going to be revised, the BCCI staff including the finance, operations and media department were not paid their daily allowances for the IPL and WPL but now that the policy has been formulated, their dues should be cleared soon.
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.
The November 5 US presidential elections, Federal Reserve interest rate decision, trading activity of foreign investors, and the upcoming quarterly earnings from domestic firms are the major triggers that would influence sentiments in the equity market this week, analysts said. In an eventful week ahead, a host of macroeconomic data announcements and global trends would also drive the markets, experts said. "The upcoming week is poised to be eventful on the global front.
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country's pharmaceuticals sector. Sanofi's partnerships with Dr Reddy's, Cipla, and Emcure, AstraZeneca and Mankind Pharma - teaming up for asthma medication distribution - are a few instances of this trend. This strategy allows MNCs to leverage established Indian networks and reach a wider audience. Indian companies also benefit from global brands and expertise, say analysts.
A war of words between Chandrababu Naidu and YSR Rajasekhar Reddy lead to commotion in the House.
'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'
The BSE Healthcare Index is up 19 per cent as compared to BSE Sensex returns of 11 per cent during this period. Nitin Agarwal of DAM Capital highlighted this trend in a report last month. "After a sustained period of underperformance over FY21-23, the BSE Healthcare Index has once again captured the spotlight. "The recent uptick in performance has been driven by hospitals and emerging green shoots in pharmaceutical exports, particularly to the US, along with sustaining momentum in domestic branded formulations," he said.
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus.
These are the top buyers of the scrapped electoral bonds, the data for which was released by the Election Commission on Thursday.
The first phase of the programme will kick off with vaccinations in Hyderabad on Monday and in Visakhapatnam on Tuesday (May 18) at Apollo facilities.
Mohit displayed immense game awareness, taking a single to bring Ashutosh on strike, bringing down the equation to five runs in four balls.
Delhi Capitals have never won the IPL despite featuring top talent over the years. Under Axar Patel's leadership, they will hope IPL 2025 finally ends their title drought.
Only in the event of the RSS managing to force Modi into accepting a consensual candidate, will the party not continue to 'being' the 'next Congress', observes Nilanjan Mukhopadhyay.
Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?
Indian drugmaker Dr Reddy's Laboratories hopes to launch two-to-three generic products in the United States this year in a bid to increase its share of a lucrative market, its chief executive said.
According to the recommendations of the Subject Expert Committee (SEC) meeting held on July 30, which have been approved by the Drugs Controller General of India (DCGI), Sputnik-Light is the same as the component-1 of Sputnik V and as its safety and immunogenicity data in the Indian population has already been generated in a trial here, there seems to be inadequate data and justification for conducting a separate, similar trial.
Benchmark indices declined for the third day running on Tuesday, with the Sensex tumbling 567.98 points amid weak global markets and continuous foreign funds outflow. Investors were risk averse ahead of the RBI's policy decision on Wednesday, traders said. The 30-share BSE Sensex tanked 567.98 points or 1.02 per cent to settle at 55,107.34.
Russian COVID-19 vaccine Sputnik V vaccine will be available in nine more cities across India, including Bengaluru, Mumbai, Chennai, Visakhapatnam, Baddi, Kolhapur and Miryalaguda, informed the official twitter handle of Sputnik V.
Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.
'There is merit in keeping the central bank's balance sheet strong if the government's fiscal balance sheet is weak.'
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India.
Axis Bank was the top loser in the Sensex pack, shedding around 2 per cent, followed by Reliance Industries, Kotak Bank, Bharti Airtel, Titan, Dr Reddy's and M&M. NSE Nifty fell by 100.55 points to 17,898.65.
Almost three months after announcing his new party, former Karnataka minister and mining baron G Janardhana Reddy on Monday announced 'football' as its poll symbol, the first list of candidates, and also manifesto, ahead of the assembly elections due by May.
While about 8,000 people are in the long list of invitees, the select list features just a few hundred people, including prominent politicians, leading industrialists, top film stars, sportspersons, bureaucrats and diplomats.
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies. Outlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments, such as deductions on R&D expenses, research-linked incentives for MNCs, and corporate tax concessions.
Given the possibilities that next year's assembly elections could throw up, Stalin told the state assembly that an interim report had to be submitted by January 2026. The outcomes may well find its way into the DMK's poll manifesto, thus seeking to keep the electoral focus still on the BJP-ruled Centre and Prime Minister Modi, observes N Sathiya Moorthy.
Jimmy Carter, the 39th president of the United States, was the third American leader to visit India during which a village in Haryana was named Carterpuri in his honour.
The mortal remains of former prime minister Dr Manmohan Singh were consigned to flames at the Nigambodh Ghat in New Delhi on Saturday amid the chanting of religious hymns. The funeral pyre was lit by his eldest daughter Upinder Singh.
Dr Theyiesinuo Keditsu, a professor of English Literature with PhD and MPhil degrees, was spotted at a restaurant. The next day she was offered Paatal Lok 2.
Equity benchmark Sensex tumbled over 273 points on Tuesday, tracking losses in index majors Reliance Industries, Dr Reddy's and Axis Bank amid a massive selloff in Chinese markets. Despite opening on a positive note, the 30-share BSE index turned red to end 273.51 points or 0.52 per cent lower at 52,578.76, while the broader NSE Nifty fell 78 points or 0.49 per cent to 15,746.45. Dr Reddy's was the top loser in the Sensex pack, plunging over 10 per cent, after the company reported s 36 per cent decline in consolidated net profit at Rs 380.4 crore for the quarter ended June 30, 2021, on account of higher expenses.
Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.
A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit.
Asian Paints was the top loser in the Sensex pack, tanking around 5 per cent, followed by Reliance Industries, Infosys, Tata Steel, TCS and Dr Reddy's.
With their respective leaders switching camps and squads undergoing major overhauls, both Delhi Capitals and Lucknow Super Giants, under new captains, will be eager to make a strong start to their IPL campaign when they face off in Visakhapatnam on Monday.
